Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alaunos Therapeutics Inc TCRT

Healthcare Biotechnology
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity... see more

Recent & Breaking News (NDAQ:TCRT)

InvestorsGuru.com 40 Filtered Mid-Day Market Movers Recap

Investors Guru May 26, 2013

Where Opportunity Is Found in NWSA, ZIOP, FCEL and DELL

Marketwired May 25, 2013

Free Research Reports on CRM, GAME, HIHO and ZIOP Issued by the Bedford Report

Marketwired May 24, 2013

ZIOPHARM Oncology to Present at the 38th Annual Deutsche Bank Health Care Conference

Globe Newswire May 22, 2013

ZIOPHARM Announces Presentation of Promising Nonclinical and Phase I Study Results of Ad-RTS-IL-12 in Advanced Melanoma at ASGCT 16th Annual Meeting

Globe Newswire May 16, 2013

ZIOPHARM Announces Poster Presentation at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting

Globe Newswire May 15, 2013

ZIOPHARM Announces First Quarter Financial Results and Key Developments

Globe Newswire May 7, 2013

MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCall's Microscope

PR Newswire April 23, 2013

Stocks Move Higher as Apple May Release New iPhone in Up to Three Different Sizes

PR Newswire April 10, 2013

ZIOPHARM Presents Preclinical Data Supporting DNA-Based IL-12 Therapy for Breast Cancer

Globe Newswire April 9, 2013

ZIOPHARM Oncology Phase 3 Trial & GameStop Report: (NASDAQ: ZIOP), (NYSE: GME)

Accesswire March 30, 2013

Investors Eye Catching Stocks: (NASDAQ: ZIOP), (NASDAQ: DCTH)

Accesswire March 27, 2013

Daytrader Accounts Climb With 100% "Stock Alerts" Throughout March

Marketwired March 27, 2013

Free Research Reports on CBMX, OPXA, PTEK and ZIOP Issued by the Bedford Report

Marketwired March 27, 2013

ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma

Globe Newswire March 26, 2013

Before the Bell Scans of MannKind, Ariad Pharma, ZIOPHARM Oncology, NPS Pharma, and Santarus

PR Newswire March 22, 2013

ZIOPHARM Reports Fourth Quarter and Full Year 2012 Financial Results

Troy Schwensen March 18, 2013

Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology

PR Newswire March 18, 2013

Stocks In Focus: (NASDAQ: ZIOP), (NASDAQ: OCZ)

Accesswire March 13, 2013

Biotech Industry Looks to Benefit From FDA's New "Breakthrough" Designation

Marketwired March 12, 2013